References
- American Cancer Society (2013). Cancer Facts & Figures 2013. Atlanta: American Cancer Society.
- Beattie WS, Lindblad T, Buckley DN, Forrest JB (1991). The incidence of postoperative nausea and vomiting in women undergoing laparoscopy is influenced by the day of menstrual-cycle. Can J Anaesth, 38, 298-302. https://doi.org/10.1007/BF03007618
- Bruix J, Sherman M, Llovet JM, et al (2001). Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol, 35, 421-30. https://doi.org/10.1016/S0168-8278(01)00130-1
- Bruix J,Sherman M (2005). Management of hepatoceullular carcinoma. Hepatology, 42, 1208-36. https://doi.org/10.1002/hep.20933
- Coates A, Abraham S, Kaye SB, et al (1983). On the receiving end--patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol, 19, 203-8. https://doi.org/10.1016/0277-5379(83)90418-2
- Coburn R, Lane J, Harrison K, Hennessey J (1993). Postoperative vomiting factors in IVF patients. Aust N Z J Obstet Gynaecol, 33, 57-60. https://doi.org/10.1111/j.1479-828X.1993.tb02055.x
- Dhand S, Gupta R (2011). Hepatic transcatheter arterial chemoembolization complicated by postembolization syndrome. Semin Intervent Radiol, 28, 207-11. https://doi.org/10.1055/s-0031-1280666
- Eisenhauer EA, Therasse P, Bogaerts J, et al (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 45, 228-47. https://doi.org/10.1016/j.ejca.2008.10.026
- Forner A, Reig ME, de Lope CR, Bruix J (2010). Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis, 30, 61-74. https://doi.org/10.1055/s-0030-1247133
- Han P, Zhang J (2007). Meta-analyses on incidences of common complications of primary liver cancer after transcatheter arterial chemoembolization. Shanghai J Prev Med, 19, 517-9.
- Harris H (1990). The human alkaline phosphatases: what we know and what we don't know. Clinica Chimica Acta, 186, 133-50. https://doi.org/10.1016/0009-8981(90)90031-M
- Honkavaara P, Lehtinen AM, Hovorka J, Korttila K (1991). Nausea and vomiting after gynecological laparoscopy depends upon the phase of the menstrual-cycle. Can J Anaesth, 38, 876-9. https://doi.org/10.1007/BF03036963
- Huppe M, Kemter A, Schmidtke C, Klotz KF (2013). [Postoperative complaints : gender differences in expectations, prevalence and appraisal]. Anaesthesist, 62, 528-36. https://doi.org/10.1007/s00101-013-2182-x
- Llovet JM, Bru C, Bruix J (1999). Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis, 19, 329-38. https://doi.org/10.1055/s-2007-1007122
- Moreno C, Veiga D, Pereira H, Martinho C, Abelha F (2013). Postoperative nausea and vomiting: Incidence, characteristics and risk factors - A prospective cohort study. Rev Esp Anestesiol Reanim, 60, 249-56. https://doi.org/10.1016/j.redar.2013.02.005
- Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP (2006). The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol, 45, 529-38. https://doi.org/10.1016/j.jhep.2006.05.013
- Sakamoto I, Aso N, Nagaoki K, et al (1998). Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics, 18, 605-19. https://doi.org/10.1148/radiographics.18.3.9599386
- Seldinger SI (1953). Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta radiol, 39, 368-76. https://doi.org/10.3109/00016925309136722
- Simurina T, Mraovic B, Skitarelic N, Andabaka T, Sonicki Z (2012). Influence of the menstrual cycle on the incidence of nausea and vomiting after laparoscopic gynecological surgery: a pilot study. J Clin Anesth, 24, 185-92. https://doi.org/10.1016/j.jclinane.2011.07.011
- Thompson HJ (1999). The management of post-operative nausea and vomiting. J Adv Nurs, 29, 1130-6. https://doi.org/10.1046/j.1365-2648.1999.00998.x
- Watcha MF, White PF (1992). Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology, 77, 162-84. https://doi.org/10.1097/00000542-199207000-00023
Cited by
- Application of Lobaplatin in Trans-catheter Arterial Chemoembolization for Primary Hepatic Carcinoma vol.15, pp.2, 2014, https://doi.org/10.7314/APJCP.2014.15.2.647
- Safety and Efficacy of Sequential Transcatheter Arterial Chemoembolization and Portal Vein Embolization prior to Major Hepatectomy for Patients with HCC vol.15, pp.2, 2014, https://doi.org/10.7314/APJCP.2014.15.2.703
- Hepatitis B Virus DNA Negativity Acts as a Favorable Prognostic Factor in Hepatocellular Carcinoma Patients vol.15, pp.22, 2014, https://doi.org/10.7314/APJCP.2014.15.22.9635
- Lobaplatin Combined Floxuridine/Pirarubicin-based Transcatheter Hepatic Arterial Chemoembolization for Unresectable Primary Hepatocellular Carcinoma vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.2057
- Phase II Study on EANI Combined with Hydrochloride Palonosetron for Prevention of Chemotherapy-induced Nausea and Vomiting Following Highly Emetogenic Chemotherapy vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.3951
- Analyses of Risk Factors and Preventive Effect of Antiemetics on Vomiting Induced by Therapy with Cisplatin Suspension in Lipiodol for Hepatocellular Carcinoma vol.41, pp.11, 2015, https://doi.org/10.5649/jjphcs.41.768
- Transarterial Therapies for Hepatocellular Carcinoma: a Comprehensive Review with Current Updates and Future Directions vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.473